Project Grant K23DK138875
Award Date
6/3/25
Completion Date
3/31/30
Dollars Obligated
$197K
Similar Awards
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,002,000 to Cedars-Sinai Medical Center to conduct a pilot randomized controlled trial (RCT) testing the clinical impact and feasibility of a virtual reality (VR) cognitive behavioral therapy (CBT) program for patients with irritable bowel syndrome (IBS). The 8-week VR CBT program,...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $316,102 to Mayo Clinic to conduct a pilot, randomized, double-blind, placebo-controlled clinical trial. The trial aims to evaluate the efficacy and safety of proteolytic activity-guided fecal microbiota transplantation (FMT) for improving symptoms in patients with...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), totals $352,125 and is focused on evaluating heart rate variability (HRV) as a biomarker for clinical symptoms and psychological functioning in pediatric patients with inflammatory bowel disease (IBD). The award will support a study to: 1) determine the relationship between baseline HRV...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $117,000.00 in funding to the Regents of the University of Michigan to conduct research on the role of substance P and its receptor MRGPRX2 in irritable bowel syndrome (IBS) pathophysiology. The research aims to delineate the underlying mechanisms of bidirectional crosstalk between...
This $1,941,591 federal Project Grant was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant is funding research to develop an objective, integrated multimodal electrophysiological (OIME) index to quantify visceral pain in patients with irritable bowel syndrome (IBS). The research aims to leverage advances in wearable sensing and telemetric technology to...
This federal Project Grant award of $604,082 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) aims to investigate the use of psyllium fiber to mitigate fructan-induced gastrointestinal symptoms in children with irritable bowel syndrome (IBS). The study, led by Duke University, will first identify children with IBS who are fructan-sensitive, then conduct a double-blind...
This $475,605 Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant aims to definitively evaluate gastric dysrhythmia as a disease mechanism underlying functional dyspepsia and chronic nausea/vomiting syndromes, which affect over 10% of the population. The project will apply a novel non-invasive diagnostic approach called Body...
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), aims to evaluate the feasibility, acceptability, adherence, safety, and potential implementation barriers of a home-based transcutaneous auricular vagus nerve stimulation (TAVNS) intervention in young adults (18-29 years old) diagnosed with irritable bowel syndrome (IBS). The $762,489 award will fund a...
The federal Project Grant award K08DK140638, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research to investigate the mechanisms of mechanosensation and inflammation-induced hypersensitivity in dorsal root ganglion (DRG) sensory neurons that innervate the colon. The $332,350 award to the President and Fellows of Harvard College, doing business as...
This Project Grant award, totaling $233,600.00 and spanning September 1, 2024 to June 30, 2027, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports high-throughput functional analyses of genetic drivers of inflammatory bowel disease (IBD), a debilitating condition characterized by chronic inflammation and erosion of intestinal functions. The...